COVID19 news

Nurses using SAMBA II - Image from NIHR Cambridge CRF
Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

Cambridge University Hospitals has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.Read more

Tactic E Logo
TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19

As part of a new trial, a microbe will be used to treat severe COVID-19 in an experimental drug known as EDP1815. Read more

Nurses using SAMBA II - Image from NIHR Cambridge CRF
Rapid COVID-19 test halves patient waiting times

A new diagnostic test that can diagnose COVID-19 in a hospital setting faster than standard testing methods has been able to halve patients waiting times.Read more

Nurse and patient - NIHR Cambridge BRC image
Cambridgeshire Trusts join COVID-19 vaccine trial

Three leading NHS Trusts in Cambridgeshire are collaborating on a COVID-19 vaccine trial which has been developed by the University of Oxford.Read more

Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.

The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more

Tactic R logo
Cambridge trial targets immune response to treat COVID-19 patients

A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more

BioRepository sample processing - NIHR Cambridge BRC image
Over 150 participants recruited to new COVID-19 research programme

A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more

Nurses using SAMBA II - Image from NIHR Cambridge CRF
NIHR Cambridge BRC and CRF begin working on new COVID-19 study

Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial into COVID-19.Read more

Fast-track HRA review of COVID-19 studies

The Health Research Authority (HRA) is working with the rest of the research system to provide a coordinated process so that COVID-19 research can progress quickly, using a fast-track review process with bespoke Read more

Recovery logo
First Addenbrooke’s Patient in National COVID-19 Trial

Today, Addenbrooke’s Hospital has enrolled our first patient into the national RECOVERY trial, led by Oxford researchers, which is hoping to identify potential treatments for COVID-19. The Randomised Evaluation of COVid-19 thERapY (RECOVERY) Read more

New National guidance for prioritising funding and support for COVID-19 research across the UK

Published by NIHR 26 March 2020:
Working with partners across the health and care system, NIHR is leading, enabling and delivering world-class COVID-19 research, a key element of the Government’s overall response to Read more

COVID-19 research studies at CUH

In response to the COVID-19 pandemic Cambridge University Hospitals has put in place measures to help researchers and research infrastructure deliver COVID-19 studies, whilst also supporting the care of patients with COVID-19 by Read more

Update on clinical research during the COVID-19 outbreak

UPDATE 7 APRIL 2020:
Approval process for COVID-19 related research
Locally, trials and studies need first to be reviewed by the Cambridge BRC/Covid-19 oversight committee before being submitted through the national NIHR prioritisation Read more

Discover more about the NIHR Cambridge BRC

Contact us by phone, email or web for more information.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.